GRCE — GRACE THERAPEUTICS, INC. (Healthcare >> Biotechnology)
GRCE FAQ
What is GRCE's P/E ratio?
GRACE THERAPEUTICS, INC. (GRCE) currently trades at a P/E ratio of 39.29.
What is GRCE's ROE?
GRACE THERAPEUTICS, INC. reports a Return on Equity (ROE) of -12.57%.
What is GRCE's dividend yield?
GRACE THERAPEUTICS, INC. offers a dividend yield of 0.00%.
What is GRCE's Deepscope Quality Score?
Deepscope rates GRCE's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy GRCE?
Deepscope's AI Timing Score for GRCE is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does GRCE belong to?
GRACE THERAPEUTICS, INC. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 2.20
Price
-0.10
(-4.35%)
Day Change
|
|
|---|
GRCE Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 46) và Thời điểm mua ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
ROA quá thấp so với ROE
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt , ...
| Yếu tố Chất lượng |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 94 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 2.20 |
| PBV / Sector |
0.55 / 4.91
GREAT
|
| Earning Per Share | -0.50 |
| PE / Sector |
39.29 / 18.34
|
| PEG or PE/Growth / Sector |
0.69 / 0.61
|
| Average 1M Daily Value |
0.66 M
GREAT
|
| Average 1W Daily Value |
0.49 M
GREAT
|
| Yếu tố Kỹ thuật |
|
28% |
| Sức khỏe tài chính |
|
45% |
| Khả năng kiếm lợi nhuận |
|
43% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-13 11:13:57 |
| Symbol | GRCE |
| Name | GRACE THERAPEUTICS, INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 15.47 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 35.59 / 9,034.83 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 103 Carnegie Center, Princeton, NJ, United States, 08540
Phone: 609 322 1602
Website: https://www.gracetx.com
Sector: Healthcare >> Biotechnology
Description: Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to improve neurological symptoms of Ataxia-Telangiectasia (A-T) and GTX-101, a topical bioadhesive film-forming polymer for the treatment of pain associated with postherpetic neuralgia (PHN). The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. Grace Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google